Knockdown or low levels of stathmin 1 could sensitise breast cancer cells to paclitaxel, vinblastine or docetaxel respectively demonstrating its importance in determining the responsiveness of cancer cells to chemotherapeutics [16, 18]. The gene discussed is STMN1; the disease is cancer.